No overall survival benefit of bevacizumab was recorded ( restricted mean survival time @ months -LSB- @ % CI @-@ -RSB- in the standard chemotherapy group vs @ months -LSB- @-@ -RSB- in the bevacizumab group ; log-rank p = @ ) .